Michael B. Yaffe
11Patents
2h-index
11Co-inventors
51Inventor score
Filing activity: Dec 11, 1997 → Jun 9, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6462173B1 | Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases | Human Necessities | 14 | Expired |
| US9320750B2 | Compositions and methods of treatment of drug resistant cancers | Chemistry; Metallurgy | 3 | Active |
| US9023787B2 | MAPKAP kinase-2 as a specific target for blocking proliferation of P53-defective | Physics | 2 | Active |
| US8440610B2 | Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells | Physics | 1 | Active |
| US6730492B2 | Cell-based screening methods | Physics | 1 | Expired |
| US7083938B2 | Cell-based screening methods | Physics | 0 | Expired |
| US10772898B2 | Combination therapies and methods of use thereof for treating cancer | Human Necessities | 0 | Active |
| US9566280B2 | Combination therapies and methods of use thereof for treating cancer | Human Necessities | 0 | Active |
| US10155006B2 | Combination therapies and methods of use thereof for treating cancer | Human Necessities | 0 | Active |
| US12115171B2 | Combination therapies and methods of use thereof for treating cancer | Human Necessities | 0 | Active |
| US9610332B2 | Compositions and methods for modulating BRD4 bioactivity | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.